Long-Term Survival of Patient with Epstein-Barr Virus-Positive Gastric Cancer Treated with Chemotherapy: Case Report.
作者信息
Yanai Hideo, Yahara Noboru, Furuya Takumi, Hayashi Hiroto, Murakami Tomoyuki, Shimokawa Yuzo, Sugihara Shigenori
机构信息
Department of Clinical Research, National Hospital Organization Kanmon Medical Center, 1-1 Sotoura, Shimonoseki, Yamaguchi, Japan.
Department of Surgery, National Hospital Organization Kanmon Medical Center, Shimonoseki, Yamaguchi, Japan.
出版信息
J Gastrointest Cancer. 2016 Mar;47(1):107-10. doi: 10.1007/s12029-015-9729-9.
PMID:25972063
Abstract
摘要
相似文献
1
Long-Term Survival of Patient with Epstein-Barr Virus-Positive Gastric Cancer Treated with Chemotherapy: Case Report.
J Gastrointest Cancer. 2016 Mar;47(1):107-10. doi: 10.1007/s12029-015-9729-9.
2
Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS).
J Gastrointest Cancer. 2015 Jun;46(2):109-17. doi: 10.1007/s12029-014-9680-1.
3
Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma.
Gastric Cancer. 2016 Jul;19(3):852-9. doi: 10.1007/s10120-015-0524-x. Epub 2015 Aug 12.
4
The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer.
World J Surg Oncol. 2016 Apr 2;14:102. doi: 10.1186/s12957-016-0845-1.
5
Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients.
World J Surg Oncol. 2014 Dec 30;12:406. doi: 10.1186/1477-7819-12-406.
6
[A phase II prospective randomized controlled trial of weekly paclitaxel combined with S-1 or fluorouracil for advanced gastric carcinoma].
Zhonghua Zhong Liu Za Zhi. 2012 Nov;34(11):865-8. doi: 10.3760/cma.j.issn.0253-3766.2012.11.015.
7
Complete response of metastatic gastric cancer to chemoimmunotherapy.
Indian J Med Res. 2017 Jul;146(1):141. doi: 10.4103/ijmr.IJMR_132_16.
8
Multicenter phase II trial of S-1, paclitaxel and cisplatin triplet combination chemotherapy in patients with advanced gastric cancer.
Cancer Chemother Pharmacol. 2011 Mar;67(3):527-32. doi: 10.1007/s00280-010-1353-6. Epub 2010 May 12.
9
Induction of a pathological complete response by four courses of neoadjuvant chemotherapy for gastric cancer: early results of the randomized phase II COMPASS trial.
Ann Surg Oncol. 2014 Jan;21(1):213-9. doi: 10.1245/s10434-013-3055-x. Epub 2013 Jul 10.
10
Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
BMC Gastroenterol. 2017 Mar 14;17(1):41. doi: 10.1186/s12876-017-0598-5.
引用本文的文献
1
Endoscopic Diagnosis and Therapy for Epstein-Barr Virus-Associated Gastric Cancer.
Microorganisms. 2023 Oct 24;11(11):2619. doi: 10.3390/microorganisms11112619.
2
Epstein-Barr virus detection in endoscopic submucosal dissection-proven early gastric cancer with mixed-type histology.
Cancer Rep (Hoboken). 2023 May;6(5):e1730. doi: 10.1002/cnr2.1730. Epub 2022 Nov 24.
3
Endoscopic and pathologic motifs for the clinical diagnosis of Epstein-Barr virus-associated gastric cancer.
DEN Open. 2021 Apr 21;1(1):e7. doi: 10.1002/deo2.7. eCollection 2021 Apr.
4
Epstein-Barr Virus-associated Early Gastric Cancer Treated with Endoscopic Submucosal Dissection: A Possible Candidate for Extended Criteria of Endoscopic Submucosal Dissection.
Intern Med. 2019;58(22):3247-3250. doi: 10.2169/internalmedicine.3055-19. Epub 2019 Nov 15.
本文引用的文献
1
Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis.
Gut. 2014 Feb;63(2):236-43. doi: 10.1136/gutjnl-2013-304531. Epub 2013 Apr 12.
2
Association between Epstein-Barr virus infection and chemoresistance to docetaxel in gastric carcinoma.
Mol Cells. 2011 Aug;32(2):173-9. doi: 10.1007/s10059-011-0066-y. Epub 2011 May 27.
3
Contribution of Epstein-Barr virus infection to chemoresistance of gastric carcinoma cells to 5-fluorouracil.
Arch Pharm Res. 2011 Apr;34(4):635-43. doi: 10.1007/s12272-011-0414-7. Epub 2011 May 5.
4
Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma.
Gastroenterology. 2010 Jul;139(1):84-92.e2. doi: 10.1053/j.gastro.2010.04.002. Epub 2010 Apr 14.
5
Gastric cancer.
Lancet. 2009 Aug 8;374(9688):477-90. doi: 10.1016/S0140-6736(09)60617-6. Epub 2009 Jul 20.
6
Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location.
Gastroenterology. 2009 Sep;137(3):824-33. doi: 10.1053/j.gastro.2009.05.001. Epub 2009 May 13.
7
Complete response of a patient with advanced gastric cancer, showing Epstein-Barr virus infection, to preoperative chemotherapy with S-1 and cisplatin.
Int J Clin Oncol. 2007 Dec;12(6):472-7. doi: 10.1007/s10147-007-0682-x. Epub 2007 Dec 21.
8
Anti-apoptotic role of BARF1 in gastric cancer cells.
Cancer Lett. 2006 Jul 8;238(1):90-103. doi: 10.1016/j.canlet.2005.06.023. Epub 2005 Jul 27.
9
High prevalence of Epstein-Barr virus in gastric remnant carcinoma after Billroth-II reconstruction.
Scand J Gastroenterol. 2002 Jul;37(7):825-9.
10
Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors.
Cancer Res. 2002 Mar 15;62(6):1920-6.
Zotero 插件